Monitoring for adverse events among patients on tuberculosis therapy.
نویسنده
چکیده
In Australia, patients with diagnosed or clinically suspected TB are treated under the guidance of a specialist with training in TB management. Standard therapy for TB follows international and Australian guidelines and traditionally involves an intensive phase of drug therapy followed by a continuation phase. The majority of treatment – with only rare exceptions – is administered by directly observed therapy (DOT) to aidwith compliance and completion of therapy. The overall goals of treatment are to cure the patient and to minimise the risk of transmission to others.
منابع مشابه
Adverse reactions associated with intravenous immunoglobulin therapy in patients with dermatologic diseases: An 11-year retrospective study
Background: Intravenous immunoglobulin (IVIG) is used to treat many autoimmune and immunodeficiency disorders. The main indications of IVIG in dermatology include treatment for resistant autoimmune bullous diseases, Stevens-Johnson syndrome (SJS), and toxic epidermal necrolysis (TEN). Although generally welltolerated, various adverse effects can occur.Methods: We designed a retrospective study ...
متن کاملAdverse Events to First Line Anti-tuberculosis Drugs in Patients Co-infected with Hiv and Tuberculosis
BACKGROUND The combination and use of multiple drugs in the treatment of tuberculosis (TB) predispose to adverse drug events and reactions. This study evaluated the incidence, frequency, and severity of adverse events to first line anti-tuberculosis (anti-TB) drugs in patients with TB and co-infections with Human Immunodeficiency Virus (HIV). OBJECTIVE The objective of this study was to deter...
متن کاملTPMT and ITPA Gene Polymorphism and Their Adverse Events during Chemotherapy of Acute Lymphoblastic Leukemia among Bangladeshi Children
Background: The pharmacogenetic-oriented approach reduces the toxicity and increases the safety of chemotherapeutic agents. 6-mercaptopurin (6-MP) metabolizing enzymes such as thiopurine S-methyltransferase (TPMT) and inosine triphosphate pyrophosphatase (ITPA) contribute to variable responses and adverse effects among leukemia patients treated with 6-MP. The aim of our study was to identify th...
متن کاملAdverse events and treatment interruption in tuberculosis patients with and without HIV co-infection RAM
Rationale: Serious treatment-associated adverse events are thought to occur more frequently in individuals with tuberculosis who are co-infected with HIV. Objectives and Methods: To assess the frequency of serious (Grade III/IV) adverse events and interruption of anti-tuberculosis treatment in the era of effective anti-retroviral therapy. We retrospectively compared the incidence of serious (Gr...
متن کاملTiming of initiation of antiretroviral drugs during tuberculosis therapy.
BACKGROUND The rates of death are high among patients with coinfection with tuberculosis and the human immunodeficiency virus (HIV). The optimal timing for the initiation of antiretroviral therapy in relation to tuberculosis therapy remains controversial. METHODS In an open-label, randomized, controlled trial in Durban, South Africa, we assigned 642 patients with both tuberculosis and HIV inf...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- New South Wales public health bulletin
دوره 24 1 شماره
صفحات -
تاریخ انتشار 2013